Bioniche Life Sciences Inc. 25 Years
Contact Us Careers
Home Investors
In the News

December 21, 2011
Bioniche Life Sciences Inc. Enters into Two Distribution Agreements for New Animal Health Products

December 13, 2011
Bioniche E. coli Vaccine Granted Import Access to Australia

Investors

Latest TSX stock price

All prices delayed at least 15 minutes.
Source: TSX Inc.

Latest ASX stock price

All prices delayed at least 20 minutes.
Source: ASX Inc.


Investor Contacts

Jennifer Shea
Vice-President, Communications, Investor & Government Relations
Tel: (613) 966-8058 ext. 1250 or (800) 265-5464
Fax: (613) 966-4177
Jennifer.Shea@Bioniche.com

Brian Ford
Vice President & CFO
Tel: (613) 966-8058 ext. 1278 or (800) 865-5464
Fax: (613) 966-4177
Brian.Ford@Bioniche.com

Copyright 2004, Bioniche Life Sciences Inc. All rights reserved  |  Legal Disclaimer  |  Privacy Policy